Expression of scinderin in megakaryoblastic leukemia cells induces differentiation, maturation, and apoptosis with release of plateletlike particles and inhibits proliferation and tumorigenesis

Blood

Volumn 98, Issue 7, 2001, Pages 2210-2219

  Zunino, Rodolfo ^a   Li, Qinggang ^a   Rosé, Sergio Daniel ^a   Itatí, María Margarita ^a   Romero Benitez ^a   Lejen, Tatiana ^a   Brandan, Nora Cristina ^a   Trifaró, José María ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; F ACTIN; FIBRINOGEN RECEPTOR; GELSOLIN; PROTEIN; SCINDERIN; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; ELECTROPHORESIS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LEUKEMIA CELL; LEUKEMOGENESIS; MEGAKARYOBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN RELEASE; SIGNAL TRANSDUCTION;

EID: 0035496925     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.7.2210     Document Type: Article

References (67)

1. Huang MJ, Li CY, Nichols WL, Young JH, Katzmann JA. Acute leukemia with megakaryocytic differentiation: a study of 12 cases identified immunocytochemically. Blood. 1984;64:427-439.
2. Lozzio DB, Lozzio CB, Bamberger EG, Feliu AS. A multipotential leukemia cell line (K562) of human origin. Proc Soc Exp Biol Med. 1981;166: 546-550.
3. Ogura M, Morishima Y, Ohno R, et al. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood. 1985;66:1384-1392.
4. Wilhide CC, Van Dang C, Dipersio J, Kennedy A, Bray P. Overexpression of Cyclin D1 in the Dami megakaryocytic cell line causes growth arrest. Blood. 1995;86:294-304.
5. MacPherson GG. Origin and development of the demarcation system in megakaryocytes of rat bone marrow. J Ultrastruct Res. 1972;40:167-177.
6. Leven RM, Yee MK. Megakaryocyte morphogenesis stimulated in vitro by whole and partially fractionated thrombocytopenic plasma: a model system for the study of platelet formation. Blood. 1987;69:1046-1052.
7. Leven RM. Differential regulation of integrin-mediated pro-platelet formation and megakaryocyte spreading. J Cell Physiol. 1995;163:597-607.
8. Kaushansky K, Broudy VC, Drachman G. The thrombopoetin receptor, Mpl, and signal transduction. In: Kuter DJ, Hunt P, Sheridan W, Zucker-Franklin D, eds. Thrombopoiesis and Thrombopoietins. Totowa, NJ: Humana Press; 1997:257-270.
9. Zauli G, Vitale M, Falcieri E, et al. In vitro senescence and apoptotic cell death in human megakaryocytes. Blood. 1997;90:2234-2243.
10. Tablin F, Castro M, Leven R. Blood platelet formation in vitro: the role of the cytoskeleton in megakaryocyte fragmentation. J Cell Sci. 1990; 97:59-70.
11. Takada M, Morii N, Kumagai S, Ryo R. The involvement of the rho gene product, a small molecular weight GTP-binding protein, in polyploidization of a human megakaryocytic cell line, CMK. Exp Hematol. 1996;24:524-530.
12. Lin SE, Yin HL, Stossel TP. Human platelets contain gelsolin: a regulator of actin filament length. J Clin Invest. 1982;69:1384-1387.
13. 2+-dependent actin filament-severing protein. Thromb Haemost. 1991;67:248-251.
14. 2+ and pH determine the interaction of chromaffin cell scinderin with phosphatidylserine and phosphatidylinositol 4,5-biphosphate and its cellular distribution during nicotinic-receptor stimulation and protein kinase C activation. J Cell Biol. 1992;119:797-810.
15. 2+-dependent F-actin severing proteins. Mol Cell Biochem. 1994;141:153-165.
16. 2+-dependent actin severing protein, is a component of the exocytotic machinery. In: Kanno T, ed. The Adrenal Chromaffin Cell. Sapporo, Japan: Hokkaido University Press; 1988:155-168.
17. Tchakarov L, Vitale ML, Veyapragesan M, Rodríguez del Castillo A, Trifaró JM. Expression of scinderin, an actin filament-severing protein, in different tissues. FEBS Lett. 1990;268:209-212.
18. Vitale ML, Rodríguez del Castillo A, Tchakarov L, Trifaró JM. Cortical filamentous actin disassembly and scinderin redistribution during chromaffin cell stimulation precede exocytosis, a phenomenon not exhibited by gelsolin. J Cell Biol. 1991;113: 1057-1067.
19. Trifaró JM, Vitale ML. Cytoskeleton dynamics during neurotransmitter release. Trends Neurosci. 1993;16:466-472.
20. Marcu MG, Zhang L, Nau-Staudt K, Trifaró JM. Recombinant scinderin, an F-actin severing protein, increases calcium-induced release of serotonin from permeabilized platelets, an effect blocked by two scinderin-derived actin-binding peptides and phosphatidylinositol 4,5-bisphosphate. Blood. 1996;87:20-24.
21. Dobo I, Allegraud A, Navenot JM, Praloran V. Collagen matrix: an attractive alternative to agar and methylcellulose for culture of hematopoietic progenitors in autologous transplantation products. J Hematother. 1995;4:281-287.
22. Hogge D, Fanning SF, Bockhold K, et al. Quantitation and characterization of human megakaryocyte colony-forming cells using a standardized serum-free assay. Br J Haematol. 1997;96:790-800.
23. Lee RW, Trifaró JM. Characterization of anti-actin antibodies and their use in immunocytochemical studies on the localization of actin in adrenal chromaffin cells in culture. Neuroscience. 1981;6: 2087-2108.
24. Vitale ML, Seward EP, Trifaró JM. Chromaffin cell cortical actin network dynamics control the size of the release-ready vesicle pool and the initial rate of exocytosis. Neuron. 1995;14:365-363.
25. Doucet JP, Trifaró JM. A discontinuous and highly porous sodium dodecyl sulfate-polyacrylamide slab gel system of high resolution. Anal Biochem. 1988;168:265-271.
26. Elzagallaaii A, Rosé SD, Trifaró JM. Platelet secretion induced by phorbol ester stimulation is mediated through phosphorylation of MARCKS: a MARCKS-derived peptide blocks MARCKS phosphorylation and serotonin release without affecting pleckstrin phosphorylation. Blood. 2000;95: 894-902.
27. Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem. 1985;260:11107-11114.
28. Congote L, Theberge F, Mazza L, Li Q. Assay for thymidine incorporation into anchorage-dependent or independent cells without filtration or cell harvesting. J Tissue Cult Methods. 1989;12:47-51.
29. Block K, Poncz M. Platelet glycoprotein IIb gene expression as a model of megakaryocyte-specific expression. Stem Cells. 1995;13:135-145.
30. Nurden P, Poujol C, Nurden A. The evolution of megakaryocytes to platelets. Baillieres Clin Haematol. 1997;10:1-26.
31. Gallagher R, Collins S, Trujillo J, et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 1979;54:713-733.
32. Rowley PT, Olsson-Wilhelm BM, Farley BA, Labella S. Inducers of erythroid differentiation of K562 human leukemia cells. Exp Hematol. 1981; 9:32-37.
33. Niitsu N, Yamamoto-Yamamuchi Y, Miyoshi H, et al. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells. Cell Growth Differ. 1996;8: 319-326.
34. Rodriguez del Castillo A, Lemaire S, Tchakarov L, et al. Chromaffin cell scinderin, a novel calcium-dependent actin filament severing protein. EMBO J. 1990;9:43-52.
35. Fedorko M. The functional capacity of guinea pig megakaryocytes. Lab Invest. 1977;36:310-320.
36. Yang M, Srikiatkhachorn A, Anthony M, Chesterman CN, Chong BH. Serotonin uptake storage and metabolism in megakaryoblasts. Int J Hematol. 1996;63:137-142.
37. Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: the platelet paradigm. Blood. 1998;91: 2645-2657.
38. Racke F, Lewandowska K, Goueli S, Goldfarb AN. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. J Biol Chem. 1997; 272:23366-23670.
39. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1995;92:7686-7689.
40. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR. Haematopoietic colony-stimulating factors promote cell survival by suppressing apoptosis. Nature. 1990;343:76-79.
41. White JG, Sauk JJ. The organization of microtubules and microtubule coils in giant platelets. Am J Pathol. 1984;116:514-522.
42. Liebermann DA, Gregory B, Hoffman B. Ap-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis. Int J Oncol. 1998; 12:685-700.
43. Smithgall T. Signal transduction pathways regulating hematopoietic differentiation. Pharmacol Rev. 1998;50:1-19.
44. Denhardt DT. Signal transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signaling. Biochem J. 1996;318:729-747.
45. Tapon N, Hall A. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol. 1997;9:86-92.
46. Behnke O. An electron microscope study of the megakaryocyte of the rat bone marrow. J Ultrastruct Res. 1968;24:412-433.
47. Behnke O. An electron microscope study of the rat megakaryocyte. J Ultrastruct Res. 1969;26: 111-129.
48. Asch H, Head K, Dong Y, et al. Widespread loss of gelsolin in breast cancers of humans mice and rats. Cancer Res. 1996;56:4841-4845.
49. Dosaka-Akita H, Hommura F, Kinoshita H, et al. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res. 1998;58:322-327.
50. Kuzumaki N, Fujita H, Tanaka M, Sakai N, Ohtsu M. Tumour suppressive function of gelsolin. In: Maruta HK, Kohama K, eds. Cytoskeleton and Cancer. Austin, TX: RG Landes; 1998:121-131.
51. Kothakota S, Azuma T, Reinhard CH, et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science. 1997;278:294-298.
52. Cao L, Wang Y. Mechanism of the formation of contractile ring in dividing cultured animals cells, II: cortical movement of microinjected actin. J Cell Biol. 1990;111:1905-1911.
53. Chatelain C, De Bast M, Symann M. Enhancement of megakaryocyte polyploidization by actin inhibitor [abstract]. Blood. 1992;80:497.
54. Takeuchi K, Ogura M, Saito H, Satoh M, Takeuchi M. Production of platelet-like particles by a human megakaryoblastic leukemia cell line (MEG-01). Exp Cell Res. 1991;193:223-226.
55. Radley JM, Harsthorn MA, Green SL. The response of megakaryocytes with processes to thrombin. Thromb Haemost. 1987;58:732-736.
56. Baatout S. The importance of cytoskeleton proteins in megakaryocyte spreading and platelet formation. Blood Rev. 1996;10:17-19.
57. Shivdasani R, Orkin SH. The transcriptional control of hematopoiesis. Blood. 1996;87:4025-4039.
58. Minden A, Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta. 1997;1333:85-104.
59. Sudgen PH, Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal. 1997;9:337-351.
60. Janmey P. The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol Rev. 1998;78:763-781.
61. Symons M. Rho family GTPases: the cytoskeleton and beyond. Trends Biochem Sci. 1996;21: 178-181.
62. Hall A. Rho GTPases and the actin cytoskeleton. Science. 1998;279:509-514.
63. Nagata K, Okano Y, Nozawa Y. Differential expression of low Mr GTP-binding proteins in human megakaryblastic leukemia cell line, MEG-01, and their possible involvement in the differentiation process. Thromb Haemost. 1997;77:368-375.
64. Arcaro A. The small GTP-binding protein Rac promotes the dissociation of gelsolin from actin filaments in neutrophils. J Biol Chem. 1998;273:805-813.
65. Azuma T, Witke W, Stossel T, Hartwig J, Kwiatowski D. Gelsolin is a downstream effector of Rac for fibroblast motility. EMBO J. 1998;17: 1362-1370.
66. Kreipe H, Radzum HJ, Heidorn K, et al. Lineage-specific expression of c-fos and c-fms in human hematopoietic cells: discrepancies with the in vitro differentiation of leukemia cells. Differentiation. 1986;33:56-60.
67. Panterne B, Hatzfeld JM, Blanchard JP, et al. c-fos mRNA constitutive expression by mature human megakaryocytes. Oncogene. 1992;7:2341-2344.